MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1081 to 1100 of 166,322 approvalsPage 55 of 8317

Lincomycin Hydrochloride Tablets

Approval Number: 国药准字H37021745
Registration: Mar 20, 2025

Oleanolic Acid Tablets

Approval Number: 国药准字H37022327
Registration: Mar 20, 2025

Clotrimazole Tablets

Approval Number: 国药准字H37021739
Registration: Mar 20, 2025

Baclofen Tablets

Approval Number: 国药准字HC20171015
Registration: Mar 19, 2025

Erdosteine Capsules

Approval Number: 国药准字HJ20150462
Registration: Mar 19, 2025
edmond pharma s.r.l

Fasudil Hydrochloride Injection

Approval Number: 国药准字HJ20150252
Registration: Mar 19, 2025

Puerarin Injection

Approval Number: 国药准字H20058539
Registration: Mar 19, 2025

Empagliflozin Tablets

Approval Number: 国药准字H20258032
Registration: Mar 19, 2025

Dexamethasone Sodium Phosphate Injection

Approval Number: 国药准字H20253644
Registration: Mar 18, 2025

Rivaroxaban Tablets

Approval Number: 国药准字H20253669
Registration: Mar 18, 2025

Rivaroxaban Tablets

Approval Number: 国药准字H20253670
Registration: Mar 18, 2025

Isavuconazonium Sulfate for Injection

Approval Number: 国药准字H20253662
Registration: Mar 18, 2025

Tadalafil Tablets

Approval Number: 国药准字H20253655
Registration: Mar 18, 2025

Nitroglycerin sublingual tablets

Approval Number: 国药准字H20253627
Registration: Mar 18, 2025

Bupivacaine Hydrochloride Injection

Approval Number: 国药准字H20253664
Registration: Mar 18, 2025

Loxoprofen Sodium Cataplasms

Approval Number: 国药准字H20253634
Registration: Mar 18, 2025

Levodopa and Benserazide Hydrochloride Tablets

Approval Number: 国药准字H20253650
Registration: Mar 18, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.